Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer

BACKGROUND: We aimed to develop a radiomic model based on pre-treatment computed tomography (CT) to predict the pathological complete response (pCR) in patients with rectal cancer after neoadjuvant treatment and tried to integrate our model with magnetic resonance imaging (MRI)-based radiomic signat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Zhuokai, Liu, Zongchao, Li, Juan, Wang, Xiaolin, Xie, Peiyi, Xiong, Fei, Hu, Jiancong, Meng, Xiaochun, Huang, Meijin, Deng, Yanhong, Lan, Ping, Yu, Huichuan, Luo, Yanxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194221/
https://www.ncbi.nlm.nih.gov/pubmed/34112180
http://dx.doi.org/10.1186/s12967-021-02919-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194221/
https://www.ncbi.nlm.nih.gov/pubmed/34112180
http://dx.doi.org/10.1186/s12967-021-02919-x

Ejemplares similares